Advertisement
Advertisement

ACET

ACET logo

Adicet Bio Inc

0.9199
USD
+0.0262
+2.93%
Dec 24, 12:59 UTC -5
Open

Adicet Bio Inc Profile

About

Adicet Bio Inc. is a biotechnology company. It engages in discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio Inc., formerly known as RESTORBIO INC, is based in Calif.

Info & Links

CEO

Chen Schor

Headquarters

131 DARTMOUTH STREET, 3RD FLOOR
BOSTON, MA 02116, UNITED STATES

Auditor

KPMG LLP

Share holders

16

Employees

143

Adicet Bio Inc Statistics

Valuation Measures

Market Capitalization2

75.80M

Enterprise Value

-29.68M

Enterprise Value/EBITDA(ttm)

0.24

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.35

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-53.85%

Return on Invested Capital(ttm)

-55.28%

Return on Assets(ttm)

-46.45%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-122.14M

Net Income Available to Common(ttm)

-117.88M

Diluted EPS(ttm)

-1.71

Share Statistics

Beta (5Y Monthly)

1.88

52-Week Change

-25.81%

S&P 500 52-Week Change

26.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

82.40M

Dividend Yield

0.00%

Float4

66.66M

% Held by Insiders

19.10%

% Held by Institutions

83.89%

Balance Sheet

Total Cash(mrq)

202.06M

Total Cash Per Share(mrq)

2.45

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

10.64%

Quick Ratio(mrq)

10.64%

Book Value Per Share(mrq)

2.57

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.75

Free Cash Flow(ytd)

-69.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement